Transparency, Power, and Influence in the Pharmaceutical Industry
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 16)

H-INDEX

(FIVE YEARS 0)

Published By University Of Toronto Press

9781487529055

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

11 The Road Forward: How Researchers Can Sustain an Ethical and Transparent Health System

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-011 ◽

2021 ◽

pp. 243-260

Author(s):

Rita Banzi

Keyword(s):

Health System ◽

The Road

7 Speak No Secrets: (Non)transparency in Health Canada’s Communications about Pharmaceutical Regulation

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-007 ◽

2021 ◽

pp. 139-158

Author(s):

Joel Lexchin

Keyword(s):

Pharmaceutical Regulation

Contributors

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-013 ◽

2021 ◽

pp. 277-280

8 The Political Economy of Influence: Ghost-Management in the Pharmaceutical Sector

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-008 ◽

2021 ◽

pp. 159-183

Author(s):

Marc-André Gagnon

Keyword(s):

Political Economy ◽

The Political ◽

Pharmaceutical Sector

3 Data Transparency and Pharmaceutical Regulation in Europe: Road to Damascus, or Room without a View?

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-003 ◽

2021 ◽

pp. 63-94

Author(s):

Courtney Davis ◽

Shai Mulinari ◽

Tom Jefferson

Keyword(s):

Pharmaceutical Regulation ◽

Data Transparency

Frontmatter

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-fm ◽

2021 ◽

pp. i-iv

9 Data Transparency and Rare Disease: Privacy versus Public Interest?

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-009 ◽

2021 ◽

pp. 184-218

Author(s):

Kanksha Mahadevia Ghimire ◽

Trudo Lemmens

Keyword(s):

Rare Disease ◽

Public Interest ◽

Data Transparency

12 Conclusion

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-012 ◽

2021 ◽

pp. 261-276

Author(s):

Katherine Fierlbeck ◽

Janice Graham ◽

Matthew Herder

4 The FDA and Health Canada: Similar Origins, yet Divergent Paths and Approaches to Transparency

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-004 ◽

2021 ◽

pp. 95-113

Keyword(s):

Health Canada

6 The Limits of Transparency and the Role of Essential Medicines

Transparency, Power, and Influence in the Pharmaceutical Industry ◽

10.3138/9781487529055-006 ◽

2021 ◽

pp. 129-138

Author(s):

Nav Persaud

Keyword(s):

Essential Medicines

Transparency, Power, and Influence in the Pharmaceutical IndustryLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By University Of Toronto Press

11 The Road Forward: How Researchers Can Sustain an Ethical and Transparent Health System

7 Speak No Secrets: (Non)transparency in Health Canada’s Communications about Pharmaceutical Regulation

Contributors

8 The Political Economy of Influence: Ghost-Management in the Pharmaceutical Sector

3 Data Transparency and Pharmaceutical Regulation in Europe: Road to Damascus, or Room without a View?

Frontmatter

9 Data Transparency and Rare Disease: Privacy versus Public Interest?

12 Conclusion

4 The FDA and Health Canada: Similar Origins, yet Divergent Paths and Approaches to Transparency

6 The Limits of Transparency and the Role of Essential Medicines

Transparency, Power, and Influence in the Pharmaceutical Industry
Latest Publications